Literature DB >> 25956243

FBXL5 modulates HIF-1α transcriptional activity by degradation of CITED2.

Gisela Machado-Oliveira1, Eduarda Guerreiro1, Ana Catarina Matias1, João Facucho-Oliveira2, Ivette Pacheco-Leyva1, José Bragança3.   

Abstract

CITED2 is a ubiquitously expressed nuclear protein exhibiting a high affinity for the cysteine-histidine-rich domain 1 (CH1) of the transcriptional co-activators CBP/p300. CITED2 is particularly efficient in the inhibition of the hypoxia-inducible factor-1α (HIF-1α) dependent transcription by competing with it for the interaction with the CH1 domain. Here we report a direct and specific interaction between CITED2 and the F-box and leucine rich repeat protein 5 (FBXL5), a substrate adaptor protein which is part of E3 ubiquitin ligase complexes mediating protein degradation by the proteasome. We demonstrated that depletion of FBXL5 by RNA interference led to an increase of CITED2 protein levels. Conversely, overexpression of FBXL5 caused the decrease of CITED2 protein levels in a proteasome-dependent manner, and impaired the interaction between CITED2 and the CH1 domain of p300 in living cells. In undifferentiated mouse embryonic stem cells, the overexpression of FBXL5 also reduced Cited2 protein levels. Finally, we evidenced that FBXL5 overexpression and the consequent degradation of CITED2 enabled the transcriptional activity of the N-terminal transactivation domain of HIF-1α. Collectively, our results highlighted a novel molecular interaction between CITED2 and FBXL5, which might regulate the steady state CITED2 protein levels and contribute to the modulation of gene expression by HIF-1α.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CITED2; FBXL5; HIF-1α; Mouse embryonic stem cells; Proteasome; TFAP2

Mesh:

Substances:

Year:  2015        PMID: 25956243     DOI: 10.1016/j.abb.2015.04.012

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  13 in total

Review 1.  Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins.

Authors:  Nana Zheng; Zhiwei Wang; Wenyi Wei
Journal:  Int J Biochem Cell Biol       Date:  2016-02-06       Impact factor: 5.085

2.  Targeting CITED2 for Angiogenesis in Obesity and Insulin Resistance.

Authors:  Guanghong Jia; James R Sowers
Journal:  Diabetes       Date:  2016-12       Impact factor: 9.461

Review 3.  New perspectives on the molecular basis of the interaction between oxygen homeostasis and iron metabolism.

Authors:  Stefania Recalcati; Elena Gammella; Gaetano Cairo
Journal:  Hypoxia (Auckl)       Date:  2015-12-11

4.  CITED2 Cooperates with ISL1 and Promotes Cardiac Differentiation of Mouse Embryonic Stem Cells.

Authors:  Ivette Pacheco-Leyva; Ana Catarina Matias; Daniel V Oliveira; João M A Santos; Rita Nascimento; Eduarda Guerreiro; Anna C Michell; Annebel M van De Vrugt; Gisela Machado-Oliveira; Guilherme Ferreira; Ibrahim Domian; José Bragança
Journal:  Stem Cell Reports       Date:  2016-11-03       Impact factor: 7.765

Review 5.  Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy.

Authors:  Sang-Min Jang; Christophe E Redon; Mirit I Aladjem
Journal:  Front Mol Biosci       Date:  2018-03-13

6.  Essential role of FBXL5-mediated cellular iron homeostasis in maintenance of hematopoietic stem cells.

Authors:  Yoshiharu Muto; Masaaki Nishiyama; Akihiro Nita; Toshiro Moroishi; Keiichi I Nakayama
Journal:  Nat Commun       Date:  2017-07-17       Impact factor: 14.919

Review 7.  CITED2 and the modulation of the hypoxic response in cancer.

Authors:  Mónica T Fernandes; Sofia M Calado; Leonardo Mendes-Silva; José Bragança
Journal:  World J Clin Oncol       Date:  2020-05-24

8.  Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis.

Authors:  Yoshiharu Muto; Toshiro Moroishi; Kazuya Ichihara; Masaaki Nishiyama; Hideyuki Shimizu; Hidetoshi Eguchi; Kyoji Moriya; Kazuhiko Koike; Koshi Mimori; Masaki Mori; Yuta Katayama; Keiichi I Nakayama
Journal:  J Exp Med       Date:  2019-03-15       Impact factor: 14.307

Review 9.  F-Box Proteins and Cancer.

Authors:  Kanae Yumimoto; Yuhei Yamauchi; Keiichi I Nakayama
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

Review 10.  F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects.

Authors:  Dinesh Singh Tekcham; Di Chen; Yu Liu; Ting Ling; Yi Zhang; Huan Chen; Wen Wang; Wuxiyar Otkur; Huan Qi; Tian Xia; Xiaolong Liu; Hai-Long Piao; Hongxu Liu
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.